Home » Authors » Mark McCarty

Articles by Mark McCarty

Congress drops FDA ball until September: layoffs could ensue

Aug. 6, 2007

By Mark McCarty

House CHIP bill hits Medicare plans, skilled nursing facilities

Aug. 3, 2007

By Mark McCarty

Failure of California RHIO offers instructive how-not-to study

Aug. 2, 2007

By Mark McCarty

Artificial hearts, VADs — still pumping up

Aug. 1, 2007

By Mark McCarty

Market updates: New guidance for neurothrombectomy no news to industry

Aug. 1, 2007

By Mark McCarty

CryoCor, Boston Sci ink agreement for AF treatment R&D

Aug. 1, 2007

By Mark McCarty

FDA warnings target problems with clinical trial investigators

Aug. 1, 2007

By Mark McCarty

CMS cancels S. Florida HMO’s Medicare Advantage contract

July 31, 2007

By Mark McCarty

Washington roundup: QUEST, newest P4P program, will gauge results in 5 areas

July 27, 2007

By Mark McCarty

Experts say HIV/AIDS vaccine essential to contain the disease

July 24, 2007

By Mark McCarty

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...